Lipid nanoparticles deliver one-two punch to shrink resistant oral tumors in preclinical models

Researchers at the University of Pennsylvania have developed a lipid nanoparticle platform to deliver mRNA therapies directly to oral squamous cell carcinoma. This new method aims to improve treatment efficacy for head and neck cancers while potentially triggering a systemic immune response against metastasis.